Jennifer Lew Annexon, Inc. (ANNX) insider trading activity

Jennifer Lew is EVP & CHIEF FINANCIAL OFFICER of Annexon, Inc.. Currently has a direct ownership of 121,616 shares of ANNX, which is worth approximately $296,743. The most recent transaction as insider was on Jul 14, 2025, when has been sold 1,117 shares (Common Stock) at a price of $2.58 per share, resulting in proceeds of $2,881. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 122K

56.38% 3M change

40.65% 12M change

Total Value Held $296,743

Jennifer Lew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 14 2025	SELL Open market or private sale	$2,881 $2.58 p/Share	1,117 Reduced 0.91%	121,616 Common Stock
Feb 18 2025	SELL Open market or private sale	$20,183 $2.92 p/Share	6,912 Reduced 8.16%	77,770 Common Stock
Feb 13 2025	SELL Open market or private sale	$5,322 $2.98 p/Share	1,786 Reduced 2.07%	84,682 Common Stock
Jul 15 2024	SELL Open market or private sale	$6,657 $6.03 p/Share	1,104 Reduced 1.26%	86,468 Common Stock
Feb 27 2024	BUY Grant, award, or other acquisition	-	44,963 Added 26.81%	122,733 Common Stock
Feb 20 2024	SELL Open market or private sale	$14,339 $5.53 p/Share	2,593 Reduced 3.06%	82,058 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	39,000 Added 31.54%	84,651 Common Stock
Feb 12 2024	SELL Open market or private sale	$10,021 $5.54 p/Share	1,809 Reduced 3.81%	45,651 Common Stock
Jul 11 2023	SELL Open market or private sale	$4,058 $3.84 p/Share	1,057 Reduced 2.18%	47,460 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	18,975 Added 28.11%	48,517 Common Stock
Feb 14 2023	SELL Open market or private sale	$1,045 $6.3 p/Share	166 Reduced 0.56%	29,542 Common Stock
Feb 13 2023	SELL Open market or private sale	$10,992 $6.31 p/Share	1,742 Reduced 5.54%	29,708 Common Stock
Jul 11 2022	BUY Grant, award, or other acquisition	-	9,375 Added 28.2%	23,875 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	12,500 Added 46.3%	14,500 Common Stock
Sep 13 2021	SELL Open market or private sale	$70,035 $20.01 p/Share	3,500 Reduced 63.64%	2,000 Common Stock
Sep 13 2021	BUY Exercise of conversion of derivative security	$26,215 $7.49 p/Share	3,500 Added 38.89%	5,500 Common Stock
May 27 2021	SELL Open market or private sale	$77,840 $22.24 p/Share	3,500 Reduced 63.64%	2,000 Common Stock
May 27 2021	BUY Exercise of conversion of derivative security	$26,215 $7.49 p/Share	3,500 Added 38.89%	5,500 Common Stock
Mar 23 2021	SELL Open market or private sale	$141,850 $28.37 p/Share	5,000 Reduced 71.43%	2,000 Common Stock
Mar 23 2021	BUY Exercise of conversion of derivative security	$37,450 $7.49 p/Share	5,000 Added 41.67%	7,000 Common Stock

Also insider at

BOLD

Boundless Bio, Inc.

Jennifer Lew

EVP & CHIEF FINANCIAL OFFICER

Brisbane, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANNX shares.

Notify only if

Value

Insider Trading

Get notified when an Annexon, Inc. insider buys or sells ANNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Annexon, Inc.

Track Activities on ANNX

Account